SENATE-BILL 927: S.927 - Protecting Pharmacies in Medicaid Act
AI-Powered Summary
SENATE-BILL 927 aims to enhance the Medicaid pharmacy reimbursement process by ensuring accurate payments and preventing abusive pricing practices, thereby improving access to medications for Medicaid beneficiaries. The bill addresses major themes of transparency in drug pricing, equitable access to pharmacy services, and the protection of individual rights. Key provisions include the requirement for the Secretary of Health and Human Services to conduct surveys to determine national average drug acquisition costs, the imposition of civil penalties on non-compliant pharmacies, and mandates for public reporting of survey data to foster accountability. Implementation requires adherence to new survey protocols and compliance measures, with potential civil penalties impacting pharmacy operations. The bill raises constitutional concerns regarding due process and equal protection, particularly in its differentiation between pharmacy types and the administrative authority granted to the Secretary, which may bypass traditional procedural safeguards. Overall, the legislation seeks to create a fairer and more transparent pharmacy environment for consumers, while also presenting challenges related to regulatory authority and privacy.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill has significant implications for individuals, particularly those reliant on Medicaid for healthcare. By ensuring fair pricing for medications, it promotes health equity and access to necessary treatments, which is crucial for vulnerable populations.
Key Individual Rights
- Right to Equal Protection (14th Amendment)
- Right to Due Process (14th Amendment)
Constitutional Provisions
- 14th Amendment - Equal Protection Clause
- 14th Amendment - Due Process Clause
Potential Constitutional Challenges Or Support
Challenges
- The implementation of civil penalties for pharmacies could raise due process concerns if deemed excessive or if pharmacies are not given adequate notice.
- If the enforcement disproportionately affects certain demographic groups, it could lead to equal protection challenges.
Support
- The bill promotes health equity by improving access to affordable medications, potentially reducing disparities among different demographic groups.
- Transparency in drug pricing aligns with principles of accountability and good governance.
Summary
SENATE-BILL 927 seeks to improve access to affordable medications for Medicaid recipients, which is particularly important for vulnerable populations such as infants, seniors, and low-income individuals. While it supports the constitutional principle of equal protection by aiming to reduce health disparities, careful implementation is necessary to avoid potential due process violations and ensure equitable access for all demographic groups.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention S. 927 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
March 11, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat